Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide with Bio-Oss for Maxillary Sinus Augmentation
NCT06061354Phase 4Unknown
- Sponsor
- Universidad de Valparaíso
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in Maxillary atrophy comparing Teriparatide with Placebo (2 arms). Primary endpoint: Histological Analysis of Bone Biopsy at 3 months. Status: unknown.
02
Drugs
teriparatide
03
Conditions
Maxillary atrophy
Beyond the preview
Go deeper on NCT06061354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06061354.